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Abstract
Background—Previous studies suggest that reducing target oxygen saturation levels to 85–93%
decreases the incidence of severe retinopathy of prematurity (ROP). Our aim was to determine if a
more modest reduction in target oxygen saturation levels also reduces ROP incidence.
Methods—One neonatal intensive care unit instituted new oxygen saturation guidelines that
changed target levels from the upper 90’s to 90–96%. We conducted a retrospective cohort study to
determine the proportion of eyes that progressed to (1) threshold or type I ROP and (2) stage 3. These
proportions were compared between two groups of all eligible infants born up to 10 months before
(higher O2 group, n = 46) and up to 16 months after (lower O2 group, n = 59) the policy change.
Binomial regression was used to calculate relative risks adjusted for birth weight, gestational age,
apnea, days of mechanical ventilation, and length of hospital stay.
Results—Sixteen of 90 eyes (18%) in the higher O2 group developed threshold or type I ROP
versus 16 of 118 eyes (14%) in the lower O2 group (adjusted relative risk = 0.66, 95% CI = 0.29,
1.51). Twenty-two of 88 eyes (25%) in the higher O2 group developed stage 3 ROP versus 26 of 118
eyes (22%) in the lower O2 group (adjusted relative risk = 0.76, 95% CI = 0.43, 1.37).
Conclusion—We observed a small but statistically insignificant reduction in the incidence of
severe ROP after a modest reduction in target oxygen saturation levels to 90–96% in the first several
weeks of life.
Introduction
In retinopathy of prematurity (ROP), abnormal retinal vascular development in premature
infants may lead to retinal detachment and permanent visual loss. ROP, formerly known as
retrolental fibroplasia (RLF), is the second leading cause of blindness in children in the United
States after cortical visual impairment.1 Peripheral retinal ablation by laser or cryotherapy is
effective in many cases in preventing retinal detachment, but those eyes that develop a retinal
detachment have a very poor visual prognosis.2 Therefore, strategies to prevent ROP are
needed, and one causative and potentially modifiable factor is supplemental oxygen use.
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Oxygen was first recognized to cause severe ROP and blindness in the 1950’s.3 At that time,
the incidence of ROP was very high because premature infants were exposed to unmonitored,
high concentrations of oxygen. After this association was recognized, oxygen was severely
restricted throughout the 1960’s. This strategy dramatically reduced the incidence of ROP;
however, it had the unexpected effect of increasing severe brain damage and death.4 Since that
time, technological advances have allowed continuous monitoring of arterial oxygen saturation
levels.
Recently, many neonatal intensive care units have reduced target oxygen saturation levels
more modestly in an attempt to decrease the incidence of ROP while avoiding increases in
neurodevelopmental morbidity or mortality. Many neonatal units have adopted new oxygen
saturation policies to reduce the amount of supplemental oxygen given to premature infants.
Implementation of these guidelines appears to have reduced the incidence of ROP.5–6
At the beginning of 2004, our neonatal intensive care unit instituted new oxygen saturation
guidelines with a targeted range of 90–96% for infants ≤ 30 weeks gestational age at birth.
Before then, oxygen saturation levels were generally kept in the upper 90’s. These new
guidelines represented a more modest reduction in oxygen saturation targets than guidelines
previously studied.5–6 The purpose of our study was to compare the risk (cumulative
incidence) of severe ROP (threshold or type I ROP) before and after this change in target
oxygen saturation levels. Our study advances previous work by assessing the effect of
potentially confounding variables such as birth weight and gestational age.
Subjects and Methods
We used a retrospective cohort study design. Eligibility criteria were: (1) birth weigh less or
equal than 1250 grams, (2) no more than one week (7 days) of the first 6 weeks of life spent
at another hospital, and (3) serial ROP examinations performed for a period of time sufficient
to determine if the outcome measures were present or absent (primary outcome = threshold or
type I ROP;7 secondary outcome = stage 3). These outcomes were considered to be absent if
they had not appeared by an examination performed at 40.5 weeks postmenstrual age or later,
or if there was complete retinal vascularization, or incomplete vascularization or ROP in zone
III. The criterion of 40.5 weeks postmenstrual age was chosen a priori because it represented
an age when approximately 85% of infants with ROP would have reached threshold,8 while
not excluding too many infants. Results of eye examinations were recorded using the
International Classification of ROP.9,10 More than 95% of examinations were performed by
one of the coauthors (DKW), who was a certified examiner for the Early Treatment for
Retinopathy of Prematurity (ETROP) study.7 We collected data from the charts of all eligible
infants born on or after October 1, 2002, except for those born between August 1, 2003, and
December 31, 2003, which was the period of time when our neonatal unit was transitioning to
the new oxygen saturation protocol. The higher oxygen group included infants born between
October 1, 2002, and July 31, 2003. Infants born before October 1, 2002, were excluded because
they participated in the ETROP Clinical Trial.7 The lower oxygen group included infants born
between January 1, 2004, and April 30, 2005. Power calculations were not done, since the
sample size was limited by the number of eligible infants. All eligible infants were included.
Institutional Review Board approval was obtained and included waiver of informed consent.
Until late 2003, oxygen saturation was generally kept in the upper 90’s, and oxygen saturations
were frequently in the range of 98–100%. The new oxygen saturation policy started late in
2003 and was fully implemented by January 1, 2004. For infants born ≤ 30 weeks postmenstrual
age, the target oxygen saturation was 90–96%, and the alarm limits were set at a low of 89%
and a high of 97%. The alarm sounded when 100 “saturation-seconds” occurred, defined as
the time in seconds multiplied by the percentage above or below the limits. For example, the
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alarm sounded when the oxygen saturation was 85% (4% below the lower limit) for 25 seconds,
or 79% (10% below the lower limit) for 10 seconds. The nursing staff attempted to maintain
these new target oxygen saturation levels as long as the infants were on oxygen. Although they
were educated with regard to the target levels, no effort was made to confirm that they were
adhering to these guidelines.
Potentially confounding variables (covariates) were identified by a priori discussion among
co-authors of possible differences in neonatal care between the higher and lower target oxygen
groups. The differences identified were (1) more frequent use in the lower oxygen group of
vitamin A supplementation and (2) high flow oxygen delivered via nasal cannula to reduce
apneic episodes. Beginning on September 27, 2004, all infants 1000g or less at birth who were
on supplemental oxygen at 24 hours of age received 12 doses over 4 weeks of 5000 international
units of vitamin A intramuscularly. Therefore, data were collected on the use of vitamin A as
well as the presence of apnea. Apnea was consistently documented in patients’ charts when
cessation of breathing occurred for 20 seconds or more based on cardiorespiratory monitoring.
We assessed other covariates because they were established strong risk factors for ROP and
could be measured accurately. These variables included birth weight, gestational age at birth,
days of mechanical ventilation, and total length of stay in the hospital. Mechanical ventilation
was a surrogate for presence and severity of lung disease, and length of stay in the hospital was
used as a marker of general health.
The primary measure of effect was the relative risk (risk ratio), defined as the risk (cumulative
incidence) of the outcome (primary = laser criteria of threshold or type I ROP, secondary =
stage 3 ROP) in the exposed (lower oxygen) group divided by the risk of the outcome in the
unexposed (higher oxygen) group. Binomial regression analysis was done to calculate crude
and adjusted risk ratios using generalized estimating equations (GEE), which allowed inclusion
of data from both eyes while accounting for the correlation between eyes of individual infants.
Analyses were conducted using SAS 9.1 (Cary, NC). Birth weight was described by 3
categories: ≤ 750 grams, 751–1000 grams, and 1001–1250 grams. Days of mechanical
ventilation was stratified into 3 categories: 0–7 days, 8–28 days, and ≥ 29 days. Total length
of stay in our hospital was described by 3 categories: 0–60 days, 61–90 days, and ≥ 91 days.
Apnea was described as present or absent. Gestational age at birth was treated as linear, because
the risk ratio estimates for both outcomes were monotonic over 4 categories of gestational age
(≤ 25 weeks, 26–27 weeks, 28 weeks, and ≥ 29 weeks). Continuous values were not used for
other variables because categorical risk ratio estimates were not monotonic. Vitamin A could
not be included as a covariate because no infants in the higher oxygen group received vitamin
A supplementation.
We used a generalized linear model with a log link and binomial distribution (binomial
regression) to estimate the risk ratio of the relationship between oxygen exposure and each
outcome. First, each covariate was tested separately in a model which included only the
exposure and the outcome. From these variables, the covariates that changed the risk ratio
estimate by at least 10% were included in a full multivariable model. We used backward
elimination to assess the effect of each covariate on the risk ratio estimate of the oxygen effect.
Covariates were removed one at a time, and in each case the variable with the highest p value
was removed first. If removal of the covariate changed the risk ratio estimate by less than 10%,
then it was kept out of the model and the next covariate was removed. This process was repeated
until removal of a covariate resulted in a change in estimate of 10% or greater. We examined
both laser criteria and stage 3 as outcomes.
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One hundred ten eyes of 55 infants in the higher oxygen group and 162 eyes of 81 infants in
the lower oxygen group had a birth weigh less or equal than 1250 grams and spent no more
than one of the first 6 weeks of life at another hospital. Of these, 90 eyes of 46 infants in the
higher oxygen group and 118 eyes of 59 infants in the lower oxygen group had an outcome
determined and were included in the primary analyses. In the higher oxygen group, 20 of 110
eyes (18%) in 11 patients were excluded because an outcome was not determined; of these,
one infant died (2 eyes), one infant developed endophthalmitis in one eye prior to ROP
screening, and 9 infants (17 eyes) were transferred to another hospital or discharged and
followed elsewhere prior to an outcome examination. (An outcome had been determined prior
to discharge in one eye but not in the other eye of one infant.) In the lower oxygen group, 44
of 162 eyes (27%) in 22 patients were excluded because an outcome was not determined; of
these, 3 infants died (6 eyes) and 19 infants (38 eyes) were transferred to another hospital or
discharged and followed elsewhere prior to an outcome examination. One infant in the higher
oxygen group was excluded because his target oxygen saturation was 92–98%; he was not
exposed to the new oxygen policy because his gestational age at birth was 31 weeks. One infant
in the higher oxygen group was excluded only from the analysis with stage 3 as the outcome
because the interval between two examinations was too long to be certain that stage 3 did not
appear and then regress without detection. The Table shows that infants in the lower oxygen
group had a lower mean birth weight (873 versus 945 grams) that was not statistically
significiant (p = 0.06).
Primary Outcome (Criteria for Laser Treatment)
Sixteen of 90 eyes (18%) in the higher O2 group developed threshold or type I ROP compared
to 16 of 118 eyes (14%) in the lower O2 group. (unadjusted risk ratio 0.78, 95% CI = 0.32,
1.89). After adjustment for birth weight, length of hospital stay, and duration of mechanical
ventilation, the risk ratio was 0.67 (95% CI = 0.30, 1.51). With adjustment for length of hospital
stay, the adjusted risk ratio was 0.66 (95% CI = 0.29, 1.51, p = 0.3), a relative reduction of
34%. (Relative reduction = 1 − adjusted risk ratio = 1 − 0.66 = 0.34)
Secondary Outcome (Stage 3 ROP)
Twenty-two of 88 eyes (25%) in the higher O2 group developed stage 3 ROP compared to 26
of 118 eyes (22%) in the lower O2 group, corresponding to an unadjusted risk ratio of 0.90
(95% CI = 0.46, 1.78). After adjustment for birth weight, gestational age, length of hospital
stay, duration of mechanical ventilation, and apnea, the risk ratio was 0.83 (95% CI = 0.47,
1.48). In a reduced model, the adjusted risk ratio was 0.76 (95% CI = 0.43, 1.37, p = 0.4) with
adjustment for birth weight and length of hospital stay, corresponding to a relative reduction
in incidence of stage 3 ROP by 24%. (Relative reduction = 1 − adjusted risk ratio = 1 − 0.76
= 0.24)
Discussion
We used a retrospective cohort design to investigate whether a modest reduction in target
oxygen saturation levels reduced the incidence of ROP in one nursery. After adjustment, our
relative risk point estimates suggested a modestly protective effect of lower oxygen target
saturation levels on the development of severe ROP. However, this single-center study had a
limited sample size. Therefore, these estimates were imprecise and were not statistically
significant.
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Other studies have reported decreases in the incidence of severe ROP after target oxygen
saturation levels were reduced, although the magnitudes of these reductions have been quite
variable. Chow and associates found a reduction in the incidence of stage 3 or 4 ROP from
12.5% in 1997 to 2.5% in 2001 and a decrease in laser treatment from 4.5% to 0% after
implementation of a strict oxygen management policy with saturation limits of 85% to 93%
for infants ≤ 32 weeks gestation.5 Tin and associates conducted an observational cohort study
to compare the incidence of severe ROP in infants with a target oxygen saturation range of 88–
98% to those with a target range of 70–90%.6 The risk of severe ROP was 27.7% (95% CI =
17.3 to 40.2%) in the higher oxygen group versus 6.2% (95% CI = 1.7 to 15.0%) in the lower
oxygen group. VanderVeen and associates studied the impact of changing oximetry alarm
limits to 85–93% with target saturations of 90–92% for those infants ≤ 32 weeks gestation.
They reported a reduction in the incidence of prethreshold ROP in at least one eye from 17.5%
(44/251 infants) to 5.6% (4/72 infants).11 Britt and Sandoval reported a reduction in the
incidence of severe ROP after institution of a policy to keep oxygen saturation between 85 and
93% for infants ≤ 30 weeks gestation. The incidence of stage 3 or more advanced ROP
decreased from 49% (18/37) to 15% (5/33), and the need for laser decreased from 38% (14/37)
to 15% (5/33). (abstract) These studies were similar to ours in that most of them used a historical
control group; however, they differed from ours in that they did not adjust for confounding
variables. By identifying and adjusting for confounding variables, we increased the
comparability of our two groups. This type of design and analysis is particularly important
when historical control groups are used, since advances in medical care and shifting patient
populations can result in groups that are not comparable.
In comparison to the aforementioned studies, our relative risk point estimates suggest a smaller
reduction in the incidence of severe ROP. One possible reason is that our target oxygen
saturation levels in the “lower” oxygen group were higher than that of the other studies. That
is, there may be a dose-response relationship between target oxygen saturation levels and risk
of severe ROP. We do not know the typical target oxygen saturation ranges of other neonatal
intensive care units, but our target ranges were higher than that of other studies. A second
possibility is that our nursery did not have procedures to insure adherence with the new oxygen
policy. In contrast, Chow and associates implemented several additional steps, including
monitoring of fraction of inspired oxygen at birth and during in-hospital transport, avoidance
of hyperoxia and repeated episodes of hypoxia-hyperoxia, and creation of teams of neonatal
nurses and respiratory therapists to help monitor adherence with the policy.5
The hypothesis that lower target oxygen saturation levels reduce the incidence of severe ROP
is biologically plausible. Premature infants are exposed to much higher blood oxygen
concentrations in the neonatal nursery compared to the intrauterine environment. Oxygen is a
potent vasoconstrictor, and prolonged vasoconstriction can lead to vasoobliteration and
peripheral retinal ischemia, initiating a cascade of events culminating in neovascularization.
12,13 In fact, this mechanism is well-established in the laboratory, and high oxygen levels are
used to create rat models of ROP.14–16 Relative hyperoxia probably has its most detrimental
effect on retinal vascular development early in life, so we chose the first 6 weeks as the critical
time of exposure in this study. Tin et al. required that infants were cared for in one of their
units for at least the first 4 weeks of life.6 Chow et al. used saturation goal limits from birth
until 2 to 8 weeks of age, depending on the gestational age at birth.5
This study must be viewed in light of some limitations. Our sample size was relatively small
because it was based on the number of eligible infants in our neonatal nursery during the time
period of interest. Therefore, our estimates of effect were imprecise, and they were not
statistically significant. As a result, we cannot conclude with certainty that reducing target
oxygen saturation decreased the incidence of severe ROP in our nursery. In addition, the small
sample size and short follow-up time did not allow us to assess possible adverse effects of
Wallace et al. Page 5













reducing target oxygen levels, such as neurodevelopmental deficits or mortality. Two studies
have found no difference in mortality or neurodevelopmental outcomes in infants randomized
to higher versus lower target oxygen saturation levels.6,17
It is also possible that we had exposure misclassification (infants in the lower oxygen group
not actually staying within their target ranges) as a result of partial lack of adherence to the
new oxygen saturation policy, since we did not formally assess compliance with the policy.
This misclassification would likely be a differential type, affecting the lower O2 group more
than the higher O2 group, since the more stringent target oxygen saturation guidelines
implemented for the lower O2 group represented a change in practice. This type of
misclassification would likely bias our results toward the null hypothesis of no difference in
severe ROP between groups. Because we did not measure oxygen saturation in this study, we
cannot know with certainty that the two groups differed in their actual oxygen saturation levels.
However, we do know that the lower O2 group was exposed to a new oxygen saturation policy
with a greater emphasis on preventing high saturation levels than the higher O2 group.
Another limitation is that we were unable to adjust for all potential confounding variables.
There were no infants in the higher oxygen group who received vitamin A supplementation,
so we were unable to adjust for this variable. However, the association between vitamin A and
decreased ROP is relatively weak and controversial.18,19 Because our study did not include
randomization, we were also unable to control for unknown or unrecognized confounding
variables. We cannot measure the impact of this limitation on our results, but we acknowledge
that the potential for confounding exists despite our efforts to adjust for important, recognized
covariates.
With regard to other potential sources of bias, this study was not conceived until 2005, so there
were very few patients examined with knowledge that the results would be used for a study. It
is notable that more infants in the lower oxygen group were excluded because they were
transferred before an outcome could be determined. These infants were likely healthier and
less likely to develop severe ROP, which could bias our results toward the null hypothesis of
finding no difference. However, our adjusted analysis should adequately account for this
potential difference between groups.
In conclusion, we found a small, statistically insignificant decrease in ROP incidence after
implementing a policy of modest reduction in target oxygen saturation levels to 90–96%.
Results from other studies support the premise that greater reductions in target oxygen
saturation levels result in larger decreases in ROP incidence. However, reducing target oxygen
saturation levels is not without potential harm, such as increasing the risks of
neurodevelopmental deficits and/or death, outcomes that were not examined in this study. Our
results reinforce the need for an adequately powered, multi-center, prospective randomized
clinical trial to control for potential confounding variables and assess long-term outcomes and
adverse events.20
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Table
Characteristics of patients in the Higher Oxygen (O2) Group (born between 10-1-02 and 7-31-03 and target oxygen
saturation in the upper 90s) and the Lower O2 Group (born between 1-1-04 and 4-30-05 and target oxygen saturation
range of 90–96%)
Higher O2 Group Lower O2 Group P value
Number of infants 46 59 -
Number of eyes 90 118 -
Mean birth weight, grams 945 873 0.06
Mean gestational age, weeks 27 27 0.4
Mean duration of mechanical ventilation, days 22 26 0.6
Mean length of hospital stay, days 79 92 0.2
Apnea, n (%) 42 (91%) 57 (97%) 0.4
Vitamin A supplementation, n (%) 0 21 (36%) <0.001
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